Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: A multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 21, Issue 7, 2014, Pages 499-508

  Uenishi, Takahiro ^a   Ariizumi, Shunichi ^b   Aoki, Taku ^c   Ebata, Tomoki ^d   Ohtsuka, Masayuki ^e   Tanaka, Eiichi ^f   Yoshida, Hiroshi ^g   Imura, Satoru ^h   Ueno, Masaki ⁱ   Kokudo, Norihiro ^c   Nagino, Masato ^d   Hirano, Satoshi ^f   Kubo, Shoji ^a   Unno, Michiaki ^g   Shimada, Mitsuo ^h   Yamaue, Hiroki ⁱ   Yamamoto, Masakazu ^b   Miyazaki, Masaru ^e   Takada, Tadahiro ^j  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF TOKUSHIMA   (Japan)

ⁱ WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^j TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Mass forming intrahepatic cholangiocarcinoma; Postoperative outcomes; Tumor node metastasis classification

Indexed keywords

ACCURACY; ARTICLE; BILE DUCT CARCINOMA; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HUMAN TISSUE; JAPANESE (PEOPLE); LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS; MULTIPLE CANCER; OVERALL SURVIVAL; TUMOR VOLUME; BILE DUCT TUMOR; INTRAHEPATIC BILE DUCT; JAPAN; MEDICAL SOCIETY; PATHOLOGY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR INVASION;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; HUMANS; JAPAN; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 84902674047     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.92     Document Type: Article

References (27)

1. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res. 2007; 37: 676-691.
2. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD,. Cholangiocarcinoma. Lancet. 2005; 366: 1303-1314.
3. Okuda K, Nakanuma Y, Miyazaki M,. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol. 2002; 17: 1049-1055.
4. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC,. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002; 37: 806-813.
5. Uenishi T, Kubo S, Yamazaki O, Yamada T, Sasaki Y, Nagano H, et al. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg. 2008; 15: 417-422.
6. Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, et al. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer. 2001; 92: 2374-2383.
7. Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, et al. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol. 2009; 16: 3048-3056.
8. Ribero D, Pinna AD, Guglielmi A, Ponti A, Nuzzo G, Giulini SM, et al. Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients. Arch Surg. 2012; 147: 1107-1113.
9. Yedibela S, Demir R, Zhang W, Meyer T, Hohenberger W, Schönleben F,. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients. Ann Surg Oncol. 2009; 16: 404-412.
10. Uchiyama K, Yamamoto M, Yamaue H, Ariizumi S, Aoki T, Kokudo N, et al. Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2011; 18: 443-452.
11. de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011; 29: 3140-3145.
12. Igami T, Ebata T, Yokoyama Y, Sugawara G, Takahashi Y, et al. Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications. World J Surg. 2011; 35: 2501-2509.
13. Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S, et al. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2005; 12: 479-483.
14. Farges O, Fuks D, Le Treut YP, Azoulay D, Laurent A, Bachellier P, et al. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group. Cancer. 2011; 117: 2170-2177.
15. Saiura A, Yamamoto J, Kokudo N, Koga R, Seki M, Hiki N, et al. Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections. Am J Surg. 2011; 201: 203-208.
16. Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery. 2000; 127: 498-505.
17. Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N,. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg. 2008; 32: 2675-2680.
18. Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, et al. Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg. 2009; 250: 950-956.
19. Gürlevik E, Fleischmann-Mundt B, Armbrecht N, Longerich T, Woller N, Kloos A, et al. Adjuvant gemcitabine therapy improves survival in a locally induced, r0-resectable model of metastatic intrahepatic cholangiocarcinoma. Hepatology. 2013; 58: 1034-1041.
20. Edge SB, editor. Intrahepatic bile ducts. AJCC cancer staging manual, 7th edn. New York: Springer; 2009.
21. Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009; 16: 14-22.
22. The Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer, Second edn. Tokyo: Kanehara; 2003.
23. Yamasaki S,. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg. 2003; 10: 288-291.
24. Terminology Committee of the IHPBA: terminology of liver anatomy and resections. HPB. 2000; 2: 333-339.
25. Ribero D, Nuzzo G, Amisano M, Tomatis M, Guglielmi A, Giulini SM, et al. Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma. HPB (Oxford). 2011; 13: 198-205.
26. Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg. 2009; 33: 1247-1254.
27. Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H,. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg. 2007; 31: 2016-2022.